Revenue Breakdown

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Mar '26 Mar 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Biotechnology Revenue	7.48B	7.29B	6.76B
Biotechnology Revenue Growth	2.54%	7.90%	-5.76%
Life Sciences Revenue	7.39B	7.33B	7.33B
Life Sciences Revenue Growth	0.78%	0.07%	2.63%
Former Life Sciences Revenue	14.87B	14.63B	14.09B
Former Life Sciences Revenue Growth	1.65%	3.83%	-1.57%
Diagnostics Revenue	9.91B	9.94B	9.79B
Diagnostics Revenue Growth	-0.32%	1.57%	2.19%
Revenue (Other)	-14.87B	-14.63B	-14.09B
Revenue (Total)	24.78B	24.57B	23.88B
Revenue (Total) Growth	0.85%	2.90%	-0.06%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Mar '26 Mar 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
North America Revenue	10.25B	10.36B	10.30B
North America Revenue Growth	-1.00%	0.59%	3.35%
Western Europe Revenue	6.16B	5.94B	5.46B
Western Europe Revenue Growth	3.72%	8.81%	-0.20%
Other Developed Markets Revenue	1.26B	1.25B	1.25B
Other Developed Markets Revenue Growth	0.48%	-0.08%	-1.34%
High-Growth Markets Revenue	7.11B	7.02B	6.87B
High-Growth Markets Revenue Growth	1.24%	2.21%	-4.46%
Revenue (Total)	24.78B	24.57B	23.88B
Revenue (Total) Growth	0.85%	2.90%	-0.06%

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Mar '26 Mar 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Recurring Revenue	20.34B	20.13B	19.37B
Recurring Revenue Growth	1.07%	3.93%	3.66%
Non-Recurring Revenue	4.44B	4.44B	4.51B
Non-Recurring Revenue Growth	-0.11%	-1.51%	-13.42%
Revenue (Total)	24.78B	24.57B	23.88B
Revenue (Total) Growth	0.85%	2.90%	-0.06%

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Mar '26 Mar 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Biotechnology Operating Income	1.96B	1.86B	1.69B
Biotechnology Operating Income Growth	4.99%	10.62%	-11.73%
Life Sciences Operating Income	544.00M	520.00M	879.00M
Life Sciences Operating Income Growth	4.61%	-40.84%	-27.30%
Former Life Sciences Operating Income	2.50B	2.38B	2.56B
Former Life Sciences Operating Income Growth	4.91%	-7.02%	-17.77%
Diagnostics Operating Income	2.61B	2.65B	2.63B
Diagnostics Operating Income Growth	-1.66%	0.95%	9.10%
Operating Income (Other)	-347.00M	-344.00M	-326.00M
Operating Income (Total)	4.76B	4.69B	4.86B
Operating Income (Total) Growth	1.49%	-3.56%	-6.52%

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Core Sales Growth	2.00%	-1.50%